Takeda Pharmaceutical Company Limited

Vir Biotechnology, Inc.

Gyorgy Pal Snell

Mary Haak-Frendscho

Vinay Bhaskar

Kathleen Ann Elias

Gregory M Landes

Wouter Korver

Andrew Walling Drake

Shweta Singh

Davide Corti

Martina Beltramello

Elisabetta Cameroni

Florian A Lempp

Dora Pinto

Amalio Telenti

Katja Fink

Shewta Singh

Gregory Landes

Isolated antibodies that bind to human CD38 and cynomolgus CD38 are disclosed. Also disclosed are pharmaceutical compositions comprising the disclosed antibodies, and therapeutic and diagnostic methods for using the disclosed antibodies.

Anti-CD38 antibodies

The instant disclosure provides antibodies and antigen-binding fragments thereof that can bind to a SARS-CoV-2 antigen and, in certain embodiments, are capable of neutralizing a SARS-CoV-2 infection. Also provided are polynucleotides that encode an antibody or antigen-binding fragment, vectors and host cells that comprise a polynucleotide, pharmaceutical compositions, and methods of using the presently disclosed antibodies, antigen-binding fragments, polynucleotides, vectors, host cells, and compositions to treat or diagnose a SARS-CoV-2 infection.

Antibodies against SARS-CoV-2 and methods of using the same

Conjugated anti-CD38 antibodies

Growing community of inventors

South San Francisco, CA, United States of America

Gyorgy Pal Snell